GSK plc
GSK
#260
Rank
NZ$166.00 B
Marketcap
NZ$82.86
Share price
-0.09%
Change (1 day)
8.91%
Change (1 year)

EPS for GSK plc (GSK)

EPS in 2026 (TTM): NZ$5.54

According to GSK plc's latest financial reports the company's current EPS (TTM) is NZ$5.70. In 2025 the company made an earnings per share (EPS) of NZ$6.71 an increase over its 2024 EPS that were of NZ$2.84.

EPS history for GSK plc from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$5.54-17.46%
2025NZ$6.71136.36%
2024NZ$2.84-47.35%
2023NZ$5.40-64.2%
2022NZ$15.07182.29%
2021NZ$5.34-18.07%
2020NZ$6.5222.34%
2019NZ$5.3323.9%
2018NZ$4.30140.61%
2017NZ$1.7964.45%
2016NZ$1.09-90.61%
2015NZ$11.57178.12%
2014NZ$4.16-48.11%
2013NZ$8.0222.68%
2012NZ$6.53-11.31%
2011NZ$7.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$11.87 108.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.35-76.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.39-40.49%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$2.26-60.42%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$11.90 108.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$1.12-80.30%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
NZ-$0.57-110.01%๐Ÿ‡บ๐Ÿ‡ธ USA